Reported results
- Total revenue of $1.889815 billion on a GAAP basis for the third quarter of 2026.
- BRUKINSA global revenues of $1.4 billion for the third quarter of 2026.
- GAAP diluted Earnings per ADS of $3.28 for the third quarter of 2026.
- Non-GAAP diluted Earnings per ADS of $4.59 for the third quarter of 2026.
- GAAP income from operations of $418.675 million for the third quarter of 2026.
- Adjusted income from operations of $612.226 million for the third quarter of 2026.
Guidance
- Full year 2026 total revenue guidance of $6.9 billion to $7.0 billion.
- Full year 2026 GAAP operating income guidance of $1.2 billion to $1.3 billion.
- Full year 2026 non-GAAP operating income guidance of $1.9 billion to $2.0 billion.
- Full year 2026 GAAP operating expenses guidance of $4.9 billion to $5.0 billion.
- Full year 2026 GAAP gross margin percentage guidance in the high-80% range.
Notes
The company reported a non-cash intangible asset impairment charge of $22 million associated with the decision to discontinue promotion of POBEVCY.
Price and volatility reaction
The stock moved +2.5% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -0.8 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 377.78 | 2026-11-04 |
| Close after release | 387.25 | 2026-11-05 |
| Realised move | +2.5% | close to close |
| 30d ATM IV change | -0.8 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
